chalcone - CISMeF

Preferred Label : chalcone;

MeSH definition : An aromatic KETONE that forms the core molecule of CHALCONES.;

MeSH synonym : benzalacetophenone; chalkone; 1,3 diphenyl 2 propen 1 one; benzylideneacetophenone; 1,3-diphenyl-2-propen-1-one;

MeSH CAS label : 2-Propen-1-one, 1,3-diphenyl-;

MeSH Related Number : 94-41-7 (Chalcone);

Registry Number MeSH : 94-41-7;

MeSH annotation : do not confuse with CHALONES see GROWTH INHIBITORS; do not confuse with CHALONES;

Wikipedia link : https://en.wikipedia.org/wiki/Chalcone;

Codes EINECS : 202-330-2;

Is substance : O;

UNII : 5S5A2Q39HX;

InChIKey : DQFBYFPFKXHELB-VAWYXSNFSA-N;

Details

Origin ID

D002599;

UMLS CUI

C0007935;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- chalcone [Substance BNPC]
Currated CISMeF NLP mapping
- chalcone [Disease (Nov.)]
- chalcones [IUPAC Term]
Record concept(s)
- chalcone [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-(2-methoxy-4,6-bis(methoxymethoxy)phenyl)-3-(3-nitrophenyl)prop-2-en-1-one [MeSH Supplementary Concept]
- 2'-ethoxy-5'-methoxy-2-(5-methylthienyl)chalcone [MeSH Supplementary Concept]
- 2-(3,4-dihydroxybenzylidene)-5-methoxybenzofuran-3(2H)-one [MeSH Supplementary Concept]
- 3,4-methylenedioxy-3',4',5'-trimethoxy chalcone [MeSH Supplementary Concept]
- 3-(3,4-dihydroxybenzylidene)-7-methoxy-2,3-dihydrochromen-4-one [MeSH Supplementary Concept]
- 3-O-methylbutein [MeSH Supplementary Concept]
- 3-phenyl-1-(2,4,6-tris(methoxymethoxy)phenyl)prop-2-yn-1-one [MeSH Supplementary Concept]
- 4'-(4-toluenesulfonylamido)-4-hydroxychalcone [MeSH Supplementary Concept]
- 4'-acetamidochalcone [MeSH Supplementary Concept]
- 4-(4-chlorophenyl)-6-(4-(propan-2-yl)phenyl)-2-oxocyclohex-3-ene-1-carboxylate [MeSH Supplementary Concept]
- 4-O-methylbutein [MeSH Supplementary Concept]
- 4-hydroxyderricin [MeSH Supplementary Concept]
- 7,9,2',4'-tetrahydroxy-8-isopentenyl-5-methoxychalcone [MeSH Supplementary Concept]
- AGL 2263 [MeSH Supplementary Concept]
- CH 401-Na [MeSH Supplementary Concept]
- MDL 27048 [MeSH Supplementary Concept]
- alpha-bromoacryloylamido indolyl pyridinyl propenone [MeSH Supplementary Concept]
- angelichalcone [MeSH Supplementary Concept]
- calythropsin [MeSH Supplementary Concept]
- carthamine [MeSH Supplementary Concept]
- cochinchinenin [MeSH Supplementary Concept]
- cycloaltilisin 6 [MeSH Supplementary Concept]
- cyclohexenyl chalcone [MeSH Supplementary Concept]
- davidigenin [MeSH Supplementary Concept]
- fissistin [MeSH Supplementary Concept]
- flavokawain A [MeSH Supplementary Concept]
- gemichalone C [MeSH Supplementary Concept]
- gemixanthone A [MeSH Supplementary Concept]
- helichrysetin [MeSH Supplementary Concept]
- hydroxysafflor yellow A [MeSH Supplementary Concept]
- isoangoletin [MeSH Supplementary Concept]
- isofissistin [MeSH Supplementary Concept]
- isolespeol [MeSH Supplementary Concept]
- isoliquiritigenin 2'-methyl ether [MeSH Supplementary Concept]
- isoliquiritin apioside [MeSH Supplementary Concept]
- isopanduratin A1 [MeSH Supplementary Concept]
- licodione [MeSH Supplementary Concept]
- neoisoliquiritin [MeSH Supplementary Concept]
- phlebodril [MeSH Supplementary Concept]
- rhuschalcone VI [MeSH Supplementary Concept]
- saffloquinoside A [MeSH Supplementary Concept]
- saffloquinoside B [MeSH Supplementary Concept]
- safflower yellow [MeSH Supplementary Concept]
- tinctormine [MeSH Supplementary Concept]
- xanthoangelol [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- benzoates [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- chalcone [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients